Cancer immunotherapy by silencing transcription factor c-Rel using peptide-based nanoparticles
BackgroundCancer immunotherapy has shown promising results in the clinic, but it faces great challenges such as low response rates and low efficacy in solid tumors. c-Rel, a member of the nuclear factor (NF)-κB family, is a newly described immune check…